Cardiovascular effect of preeclampsia upon offspring development: Are (Pro) renin-renin receptor ((P)RR) and gender

Lourdes Graciela Baeza-Pérez1,2, Sandra Edith Cabrera-Becerra3, Rodrigo Romero-Nava3

  • 1Laboratorio de Farmacología Molecular, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina del Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón s/n, Casco de Sto. Tomás, Ciudad de México, México.

Insights

Preeclampsia in mothers can lead to hypertension in offspring, particularly males. The (Pro)renin receptor ((P)RR) pathway is implicated, but treatment with handle region peptide (HRP) shows promise in normalizing blood pressure.

Area of Science:

  • Cardiovascular Physiology
  • Developmental Biology
  • Endocrinology

Background:

  • Preeclampsia (PE) is a pregnancy complication linked to long-term cardiovascular and metabolic risks in offspring.
  • The renin-angiotensin-aldosterone system, including the (Pro)renin receptor ((P)RR), is implicated in cardiovascular pathology.

Purpose of the Study:

  • To investigate the role of (P)RR in cardiovascular and renal tissues of offspring from preeclamptic rat dams.
  • To evaluate the impact of preeclampsia on offspring blood pressure and tissue morphology.

Main Methods:

  • Offspring from normal and preeclamptic rats were monitored for blood pressure and organ weight for 3 months.
  • Animals received either handle region peptide (HRP) or vehicle.
  • Tissue analysis included immunoblotting and RT-PCR for (P)RR, PLZF, β-catenin, DVL-1, and PKCα.

Main Results:

  • Preeclampsia offspring developed hypertension, with males showing persistent hypertension.
  • HRP treatment normalized blood pressure and reversed morphological changes in heart, aorta, and kidney.
  • (P)RR, PLZF, and WNT pathway molecules were upregulated in PE offspring, and HRP treatment abolished this increase.

Conclusions:

  • Preeclampsia induces hypertension in offspring, with gender-specific responses.
  • (P)RR activation via the canonical WNT pathway is a key mechanism.
  • HRP treatment offers a potential therapeutic strategy for PE-induced offspring cardiovascular dysfunction.
Abstract

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.1K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.6K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
613